Análise da expressão de RNAs longos não-codificadores em linhagens celulares de melanoma em diferentes estágios de progressão tumoral

Autor: Siena, Ádamo Davi Diógenes

Evidências sugerem que somente cerca de 2% do genoma codifica proteínas, mas que a maior parte dos 80% restante possui atividade transcricional. Por não ser codificadora de proteínas, essa fração do genoma foi considerada como \'DNA lixo\'. Ent

Externí odkaz: http://www.teses.usp.br/teses/disponiveis/17/17135/tde-04012017-084739/

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Contributions of HOX genes to cancer hallmarks: Enrichment pathway analysis and review.

Autor: Brotto, Danielle Barbosa, Siena, Ádamo Davi Diógenes, de Barros, Isabela Ichihara, Carvalho, Simone da Costa e Silva, Muys, Bruna Rodrigues, Goedert, Lucas, Cardoso, Cibele, Plaça, Jessica Rodrigues, Ramão, Anelisa, Squire, Jeremy Andrew, Araujo, Luiza Ferreira, Silva Jr, Wilson Araújo da

Publikováno v: Tumor Biology (IOS Press); May2020, Vol. 42 Issue 5, p1-16, 16p, 2 Diagrams, 1 Chart

Contributions of HOX genes to cancer hallmarks: Enrichment pathway analysis and review.

Autor: Brotto DB; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National Institute of Science and Technology in Stem Cell and Cell Therapy (INCT/CNPq) and Center for Cell-Based Therapy, CEPID/FAPESP, Ribeirão Preto, Brazil., Siena ÁDD; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National Institute of Science and Technology in Stem Cell and Cell Therapy (INCT/CNPq) and Center for Cell-Based Therapy, CEPID/FAPESP, Ribeirão Preto, Brazil., de Barros II; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National Institute of Science and Technology in Stem Cell and Cell Therapy (INCT/CNPq) and Center for Cell-Based Therapy, CEPID/FAPESP, Ribeirão Preto, Brazil., Carvalho SDCES; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National Institute of Science and Technology in Stem Cell and Cell Therapy (INCT/CNPq) and Center for Cell-Based Therapy, CEPID/FAPESP, Ribeirão Preto, Brazil., Muys BR; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National Institute of Science and Technology in Stem Cell and Cell Therapy (INCT/CNPq) and Center for Cell-Based Therapy, CEPID/FAPESP, Ribeirão Preto, Brazil., Goedert L; National Institute of Science and Technology in Stem Cell and Cell Therapy (INCT/CNPq) and Center for Cell-Based Therapy, CEPID/FAPESP, Ribeirão Preto, Brazil.; Department of Cell and Molecular Biology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Cardoso C; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National Institute of Science and Technology in Stem Cell and Cell Therapy (INCT/CNPq) and Center for Cell-Based Therapy, CEPID/FAPESP, Ribeirão Preto, Brazil., Plaça JR; National Institute of Science and Technology in Stem Cell and Cell Therapy (INCT/CNPq) and Center for Cell-Based Therapy, CEPID/FAPESP, Ribeirão Preto, Brazil., Ramão A; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National Institute of Science and Technology in Stem Cell and Cell Therapy (INCT/CNPq) and Center for Cell-Based Therapy, CEPID/FAPESP, Ribeirão Preto, Brazil., Squire JA; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada., Araujo LF; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National Institute of Science and Technology in Stem Cell and Cell Therapy (INCT/CNPq) and Center for Cell-Based Therapy, CEPID/FAPESP, Ribeirão Preto, Brazil., Silva WAD Jr; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National Institute of Science and Technology in Stem Cell and Cell Therapy (INCT/CNPq) and Center for Cell-Based Therapy, CEPID/FAPESP, Ribeirão Preto, Brazil.; Center for Integrative System Biology (CISBi), NAP/USP, University of São Paulo, Ribeirão Preto, Brazil.; Center for Medical Genomics, Clinics Hospital, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

Publikováno v: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine [Tumour Biol] 2020 May; Vol. 42 (5), pp. 1010428320918050.